Conditions: Cancer
Interventions: Drug: Metformin; Drug: sulphonylurea; Drug: DPP-4 inhibitor; Drug: GLP-1 Receptor Agonists; Drug: SGLT-2 inhibitor; Drug: insulin; Drug: MET + SU; Drug: MET + DPP-4 inhibitor; Drug: MET + GLP-1RA; Drug: MET + SGLT2i; Drug: MET + INS
Sponsors: University of Pecs
Completed Conditions: Cancer
Interventions: Drug: Metformin; Drug: sulphonylurea; Drug: DPP-4 inhibitor; Drug: GLP-1 Receptor Agonists; Drug: SGLT-2 inhibitor; Drug: insulin; Drug: MET + SU; Drug: MET + DPP-4 inhibitor; Drug: MET + GLP-1RA; Drug: MET + SGLT2i; Drug: MET + INS
Sponsors: University of Pecs
Completed
